FRIFIX: Minimally Invasive Reduction and Fixation of Thoracolumbar Fractures

Sponsor
Aesculap AG (Industry)
Overall Status
Completed
CT.gov ID
NCT01810094
Collaborator
(none)
24
4
45
6
0.1

Study Details

Study Description

Brief Summary

Spinal injuries, such as vertebral fractures, often result in a significant instability of the spine and lead to acute or delayed neurological deficits. Depending on the type of injury there are various methods available to stabilize the spine. The proposed study should clarify whether the combined reduction and fixation with a minimally invasive approach can actually be done with the same precision as in a conventional approach. The primary endpoint of this investigation is the monosegmental anterior wedge angle (AWA), and its maintenance over the first 6 postoperative weeks. It is the aim of the study to gather key radiological, clinical and subjective patient outcome parameters for its patient population that will allow to compare the results to a historical group of patients. The study design is non-interventional, prospective, open,and multicentric.

Condition or Disease Intervention/Treatment Phase
  • Device: Fracture Fixation

Study Design

Study Type:
Observational
Actual Enrollment :
24 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Prospective Observational Study of Minimally Invasive Fixation of Thoracolumbar Fractures With the Fracture Fixation System S4, Performed With the Fracture Reduction Instrumentation FRI (FRIFIX)
Actual Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Oct 1, 2014
Actual Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Minimally invasive Approach

Patients with a thoracolumbar Fracture A3.1 to A 3.3 treated by fracture fixation by a minimally invasive approach

Device: Fracture Fixation
Thoracolumbar Fracture Fixation

Outcome Measures

Primary Outcome Measures

  1. Anterior wedge angle (AWA) [6 weeks]

Secondary Outcome Measures

  1. Blood loss of the patient during surgery to stabilize the spine fracture [intraoperative]

  2. OP duration [intraoperative]

  3. Adverse events [Intraop and Postop]

  4. VAS Spine Score [3 days and 6 weeks]

  5. VAS pain score [3 days and 6 weeks]

  6. accompanying pain medication (or "self medication") [6 weeks]

  7. patient satisfaction with operational results [6 weeks]

    The patient is asked the question whether he is satisfied with the results of the operation, he has the choice between six answers: very satisfied, satisfied, partly satisfied, unsatisfied, no comment

  8. Hospital length of stay [discharge]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Minimum age of the patients of 18 years

  • Indication for operative treatment of fractures of the thoracic or lumbar spine

  • Singular A3.1-3 fractures according to the AO classification system

  • Declaration of consent in participation in this study and willingness to the treatment according to the study protocol

  • Physical and mental ability to meet the clinical and radiological follow-up plan

Exclusion Criteria:
  • Additional severe trauma, that makes survey of the patient difficult or impossible influence the results of the fracture treatment significantly

  • Additional trauma or fractures of the spine

  • Other serious conditions complicating participation in the study

  • Systemic or local infections

  • Pregnancy or planned pregnancy

  • Neurological deficits

  • Severe blood coagulation disorders diagnosed preoperatively

  • Intake of preoperatively anticoagulants

  • Osteoporosis

  • Bone metabolism disorders

  • Laminectomy necessary during surgery results in exclusion of the patient either

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vinzenz-Pallotti-Hospital Bergisch Gladbach Germany 51429
2 Universitätsklinik Bonn, Abteilung für Unfallchirurgie Bonn Germany 53127
3 Klinik für Unfall-, Hand- und Wiederherstellungschirurgie, Universitätsklinik Köln Köln Germany 50924
4 Abteilung für Orthopädie und Unfallchirurgie, Krankenhaus Wermelskirchen Wermelskirchen Germany 42929

Sponsors and Collaborators

  • Aesculap AG

Investigators

  • Principal Investigator: Hans Goost, MD, University Hospital, Bonn

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aesculap AG
ClinicalTrials.gov Identifier:
NCT01810094
Other Study ID Numbers:
  • AAG-O-H-0910
First Posted:
Mar 13, 2013
Last Update Posted:
Jan 26, 2017
Last Verified:
Jan 1, 2017
Keywords provided by Aesculap AG
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2017